In today’s dose, there’s news on medical marijuana, open-source research, fat across the sexes, and a new FDA partnership.
— GlaxoSmithKline has posted an online list of 13,500 compounds that the company has designed for functionality against the malaria parasite. The open-source approach aims to narrow the list of potential therapies, aiding in the development of malaria treatments, much like GSK’s ‘patent pool’ program. (WSJ)
— Medical marijuana opponents are fired up over violence involving dispensaries across the US. Several cities have also seen booming numbers of stores and patients, leading to problems with oversight. (WSJ)
— If you’ve ever Googled a medication, you’ve probably seen Drugs.com among the top results. Now, the US Food and Drug Administration (FDA) says it will partner with the site to expand access to agency-approved consumer information. According to the FDA, Drugs.com has more than 12 million unique visitors each month.
— Fat is a touchy subject between men and women, but new genetic research offers a partial explanation for our differences. A mouse study in the news showed that among more than 1,000 fat-specific genes, only 138 genes were active in both the male and female rodents. (LATimes)
Image by Torben Bjørn Hansen via Flickr Creative Commons
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research